These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24168306)

  • 1. Anti-glucagon-like peptide-1 immunoreactivity in samples of blood and ileum obtained from neonatal and adult alpacas.
    Smith CC; Cebra CK; Heidel JR; Stang BV
    Am J Vet Res; 2013 Nov; 74(11):1409-14. PubMed ID: 24168306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects.
    Steinert RE; Poller B; Castelli MC; Friedman K; Huber AR; Drewe J; Beglinger C
    Clin Pharmacol Ther; 2009 Dec; 86(6):644-50. PubMed ID: 19727071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of K and L cells in the feline intestinal tract.
    Gilor C; Gilor S; Graves TK; Borst LB; Labelle P; Ridge TK; Santoro D; Dossin O
    Domest Anim Endocrinol; 2013 Jul; 45(1):49-54. PubMed ID: 23751572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-monoclonal, sandwich immunoassay specific for glucagon like peptide-19-36/7 (GLP-19-36/7).
    Osborne RI; Ming W; Troutt JS; Siegel RW; Konrad RJ
    Clin Biochem; 2016 Aug; 49(12):897-902. PubMed ID: 27208557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and intestinal concentrations of GIP and GLP-1 (7-36) amide during suckling and after weaning in pigs.
    Knapper JM; Morgan LM; Fletcher JM; Marks V
    Horm Metab Res; 1995 Nov; 27(11):485-90. PubMed ID: 8770623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and effects of glucagon-like peptide-1 (7-36) amide in calves before and after weaning.
    Fukumori R; Mita T; Sugino T; Obitsu T; Taniguchi K
    Domest Anim Endocrinol; 2012 Nov; 43(4):299-306. PubMed ID: 22683323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
    Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
    Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes.
    Zambrowicz B; Ding ZM; Ogbaa I; Frazier K; Banks P; Turnage A; Freiman J; Smith M; Ruff D; Sands A; Powell D
    Clin Ther; 2013 Mar; 35(3):273-285.e7. PubMed ID: 23433601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
    Creutzfeldt W
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cardiac troponin I utilizing a point of care analyzer in healthy alpacas.
    Blass KA; Kraus MS; Rishniw M; Mann S; Mitchell LM; Divers TJ
    J Vet Cardiol; 2011 Dec; 13(4):261-6. PubMed ID: 22030292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption.
    Bodinham CL; Al-Mana NM; Smith L; Robertson MD
    Br J Nutr; 2013 Oct; 110(8):1429-33. PubMed ID: 23507477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of vitamin D status of llamas and alpacas with hypophosphatemic rickets.
    Van Saun RJ; Smith BB; Watrous BJ
    J Am Vet Med Assoc; 1996 Sep; 209(6):1128-33. PubMed ID: 8800263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus.
    Hillman M; Eriksson L; Mared L; Helgesson K; Landin-Olsson M
    J Cyst Fibros; 2012 Mar; 11(2):144-9. PubMed ID: 22138561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of parturition in alpacas and subsequent survival of neonates.
    Bravo PW; Bazan PJ; Troedsson MH; Villalta PR; Garnica JP
    J Am Vet Med Assoc; 1996 Nov; 209(10):1760-2. PubMed ID: 8921038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of buprenorphine and sustained-release buprenorphine after administration to adult alpacas.
    Dooley SB; Aarnes TK; Lakritz J; Lerche P; Bednarski RM; Hubbell JA
    Am J Vet Res; 2017 Mar; 78(3):321-329. PubMed ID: 28240955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal sensitivity in healthy, immature, and adult alpacas.
    Rankin AJ; Hosking KG; Roush JK
    Vet Ophthalmol; 2012 Jan; 15(1):31-5. PubMed ID: 22051098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection.
    Bendet N; Scapa E; Cohen O; Bloch O; Aharoni D; Ramot Y; Weiss M; Halevi A; Rapoport MJ
    Scand J Gastroenterol; 2004 Jul; 39(7):650-6. PubMed ID: 15370686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.